Outlook Therapeutics Announces Closing of $57.5 Million Bought Deal, Including Full Exercise of Underwriter's Option to Purchase Additional Shares
Stock Information for Outlook Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.